Ellias Helen K. has filed 3 insider transactions across 1 company since November 2024.
Most recent transaction: a grant/award of 150000 shares of SAB Biotherapeutics, Inc. ($SABS) on December 16, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 16, 2025 | SAB Biotherapeutics, Inc. | $SABS | Ellias Helen K. | Not found | A | Stock Option (right to buy) | 150000 | $0.00 | 150,000.0000 | 77,863,263 | 9999.99% | 0.19% |
| Nov. 1, 2024 | SAB Biotherapeutics, Inc. | $SABS | Ellias Helen K. | Not found | A | Stock Option (right to buy) | 20000 | $0.00 | 20,000.0000 | 9,259,192 | 9999.99% | 0.22% |
| Nov. 1, 2024 | SAB Biotherapeutics, Inc. | $SABS | Ellias Helen K. | Not found | A | Stock Option (right to buy) | 35000 | $0.00 | 35,000.0000 | 9,259,192 | 9999.99% | 0.38% |